"Seriously Don't Think You're Ready for the U.S. Just Because You Have a Product"European healthtech founders — listen up. Just having a product (even a great one) doesn’t mean you’re ready for the U.S. market. In this session, Dan Griffith is joined by U.S. market entry expert John Vislosky to break down the most expensive mistakes startups make when crossing the Atlantic — and how to avoid them.✅ Why FDA clearance ≠ go-to-market strategy ✅ The real decision-makers in U.S. healthcare ✅ How to think about reimbursement, pricing, and GTM timing ✅ What founders get wrong about hiring and selling in the U.S. ✅ The NHS vs. U.S. buyer journey — it’s not even close📦 Tools, takeaways, and truth bombs — all in one episode.LinkedIn | WEBSITE

Ver todos los episodios